Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Tiemann

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Blood|June 5, 2001
Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90K Seidemann, M Tiemann, M Schrappe, et al.
British Journal of Haematology|February 26, 2000
Recurrent B-cell non-Hodgkin's lymphoma in two brothers with X-linked lymphoproliferative disease without evidence for Epstein-Barr virus infectionB Strahm, K Rittweiler, U Duffner, et al.
ACS Nano|January 27, 2015
Preparation and in vitro antimicrobial activity of silver-bearing degradable polymeric nanoparticles of polyphosphoester-block-poly(L-lactide)Young H Lim, Kristin M Tiemann, Gyu Seong Heo, et al.
American Journal of Hematology|January 5, 2002
Cytogenetic and molecular characterization of a patient with simultaneous B-cell chronic lymphocytic leukemia and peripheral T-cell lymphomaJ I Martin-Subero, R Siebert, L Harder, et al.
Der Pathologe|August 12, 2016
[Predictive PD-L1 immunohistochemistry for non-small cell lung cancer : Current state of the art and experiences of the first German harmonization study]A H Scheel, M Dietel, L C Heukamp, et al.
Blood|November 24, 1999
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90A Reiter, M Schrappe, M Tiemann, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2017
Synthesis, characterization, in vitro SAR and in vivo evaluation of N,N'bisnaphthylmethyl 2-alkyl substituted imidazolium salts against NSCLCMichael A DeBord, Marie R Southerland, Patrick O Wagers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study GroupW Hiddemann, M Unterhalt, R Herrmann, et al.
Leukemia|May 1, 1996
Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study GroupM Unterhalt, R Herrmann, M Tiemann, et al.
Scientific Reports|May 22, 2026
Mast cell-driven remodeling of pulmonary immune and stromal landscapes in COVID-19D A Atiakshin, O A Burgasova, A A Kostin, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Blood|June 5, 2001
Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90K Seidemann, M Tiemann, M Schrappe, et al.
British Journal of Haematology|February 26, 2000
Recurrent B-cell non-Hodgkin's lymphoma in two brothers with X-linked lymphoproliferative disease without evidence for Epstein-Barr virus infectionB Strahm, K Rittweiler, U Duffner, et al.
ACS Nano|January 27, 2015
Preparation and in vitro antimicrobial activity of silver-bearing degradable polymeric nanoparticles of polyphosphoester-block-poly(L-lactide)Young H Lim, Kristin M Tiemann, Gyu Seong Heo, et al.
American Journal of Hematology|January 5, 2002
Cytogenetic and molecular characterization of a patient with simultaneous B-cell chronic lymphocytic leukemia and peripheral T-cell lymphomaJ I Martin-Subero, R Siebert, L Harder, et al.
Der Pathologe|August 12, 2016
[Predictive PD-L1 immunohistochemistry for non-small cell lung cancer : Current state of the art and experiences of the first German harmonization study]A H Scheel, M Dietel, L C Heukamp, et al.
Blood|November 24, 1999
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90A Reiter, M Schrappe, M Tiemann, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2017
Synthesis, characterization, in vitro SAR and in vivo evaluation of N,N'bisnaphthylmethyl 2-alkyl substituted imidazolium salts against NSCLCMichael A DeBord, Marie R Southerland, Patrick O Wagers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Mantle-cell lymphomas have more widespread disease and a slower response to chemotherapy compared with follicle-center lymphomas: results of a prospective comparative analysis of the German Low-Grade Lymphoma Study GroupW Hiddemann, M Unterhalt, R Herrmann, et al.
Leukemia|May 1, 1996
Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study GroupM Unterhalt, R Herrmann, M Tiemann, et al.
Scientific Reports|May 22, 2026
Mast cell-driven remodeling of pulmonary immune and stromal landscapes in COVID-19D A Atiakshin, O A Burgasova, A A Kostin, et al.
Pageof 10